• Alzerta 13.3 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	19,2 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Esteve Pharmaceuticals S.A.

• Alzerta 4.6 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	6,9 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Esteve Pharmaceuticals S.A.

• Alzerta 9.5 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	13,8 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Esteve Pharmaceuticals S.A.

• Alzerta Two Times Weekly 4.6 mg/24 h transdermal patches

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	25,92 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Esteve Pharmaceuticals S.A.

• Alzerta Two Times a Week 9.5 mg/24 h transdermal patches

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	51,84 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Esteve Pharmaceuticals S.A.

• Exelon 1.5 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE	1,5 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Novartis Europharm Limited

• Exelon 1.5 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE	1,5 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Novartis Europharm Limited

• Exelon 1.5 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE	1,5 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Novartis Europharm Limited

• Exelon 13.3 mg/24 h transdermal patch

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	27 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Novartis Europharm Limited

• Exelon 2 mg/ml oral solution

  Form: solution, oral

  Active substance	Dosage
  RIVASTIGMINE	2 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Novartis Europharm Limited

• Exelon 3 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE	3 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Novartis Europharm Limited

• Exelon 3 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE	3 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Novartis Europharm Limited

• Exelon 4.5 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE	4,5 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Novartis Europharm Limited

• Exelon 4.5 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE	4,5 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Novartis Europharm Limited

• Exelon 4.6 mg/24 h transdermal patch

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	4,6 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Novartis Europharm Limited

• Exelon 6 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE	6 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Novartis Europharm Limited

• Exelon 6 mg hard capsules

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE	6 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Novartis Europharm Limited

• Exelon 9.5 mg/24 h transdermal patch

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	9,5 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Novartis Europharm Limited

• Prometax 13.3 mg/24 h transdermal patch

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	27 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Almirall S.A.

• Prometax 4.6 mg/24 h transdermal patch

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	4,6 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Almirall S.A.

• Prometax 9.5 mg/24 h transdermal patch

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	9,5 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Almirall S.A.

• Rivanex 13.3 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	27 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Neuraxpharm Spain S.L.

• Rivanex 4.6 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	9 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Neuraxpharm Spain S.L.

• Rivanex 9,5 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	18 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Neuraxpharm Spain S.L.

• Rivastigmine Aristo 4.6 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	7,5 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Aristo Pharma Iberia S.L.

• Rivastigmine Aristo 9.5 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	13,8 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Aristo Pharma Iberia S.L.

• Rivastigmine Aurovitas Spain 13.3 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	19,2 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Aurovitas Spain, S.A.U.

• Rivastigmine Aurovitas Spain 4.6 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	6.9 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Aurovitas Spain, S.A.U.

• Rivastigmine Aurovitas Spain 9.5 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	13.8 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Aurovitas Spain, S.A.U.

• Rivastigmine CINFA 13.3 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	27 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Laboratorios Cinfa S.A.

• Rivastigmine CINFA 9.5 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	18 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Laboratorios Cinfa S.A.

• Rivastigmine Cinfac 4.6 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	9 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Laboratorios Cinfa S.A.

• Rivastigmine Kern Pharma 13.3 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	27,00 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Kern Pharma S.L.

• Rivastigmine Kern Pharma 4.6 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	9 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Kern Pharma S.L.

• Rivastigmine Kern Pharma 9.5 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	18 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Kern Pharma S.L.

• Rivastigmine Normon 2 mg/ml oral solution EFG

  Form: solution, oral

  Active substance	Dosage
  RIVASTIGMINE	2 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Laboratorios Normon S.A.

• Rivastigmine Sandoz 13.3 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	27 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Sandoz Farmaceutica S.A.

• Rivastigmine Sandoz 4.6 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	9 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Sandoz Farmaceutica S.A.

• Rivastigmine Sandoz 9.5 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	18 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Sandoz Farmaceutica S.A.

• Rivastigmine Stadafarma 13.3 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	19.2 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Laboratorio Stada S.L.

• Rivastigmine Stadafarma 4.6 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	6,9 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Laboratorio Stada S.L.

• Rivastigmine Stadafarma 9.5 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	13,8 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Laboratorio Stada S.L.

• Rivastigmine Tecnigen 9.5 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	18 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Tecnimede Espana Industria Farmaceutica S.A.

• Rivastigmine Teva 13.3 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	27 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Teva Pharma S.L.U.

• Rivastigmine Teva 4.6 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	9 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Teva Pharma S.L.U.

• Rivastigmine Teva 9.5 mg/24 h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	18 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Teva Pharma S.L.U.

• Rivastigmine Viatris 4.6 mg/24h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	7,5 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Viatris Limited

• Rivastigmine Viatris 9.5 mg/24h transdermal patches EFG

  Form: patches, transdermal

  Active substance	Dosage
  RIVASTIGMINE	13,8 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Viatris Limited

• Rivastigmine Vir 1.5 mg hard capsules EFG

  Form: capsules, hard

  Active substance	Dosage
  RIVASTIGMINE	1,5 mg

  ATC: N06D N06DA N06DA03

  Manufacturer: Industria Quimica Y Farmaceutica Vir S.A.